The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis-Reference-Cited by-同舟云学术

The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis

Published:2018-07-19 Issue:2 Volume:219 Page:254-263
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Borges Álvaro H¹,Neuhaus Jacqueline²,Sharma Shweta²,Neaton James D²,Henry Keith³,Anagnostou Olga⁴,Staub Teresa⁵,Emery Sean⁶,Lundgren Jens D¹, ,

Affiliation:

1. Center of Excellence for Health, Infections and Immunity, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark

2. Division of Biostatistics, School of Public Health, University of Minnesota

3. Hennepin County Medical Center, Minneapolis, Minnesota

4. University of Athens, Greece

5. Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses, Luxembourg

6. Faculty of Medicine, University of Queensland, Brisbane, Australia

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Agence Nationale de Recherches sur le SIDA et les Hipatites Virales

National Health and Medical Research Council

Danish National Research Foundation

Bundesministerium für Bildung und Forschung

European AIDS Treatment Network

Medical Research Council

National Institute for Health Research

National Health Service

University of Minnesota

AbbVie

Bristol-Myers Squibb

Gilead Sciences

GlaxoSmithKline

ViiV Healthcare

Janssen Scientific Affairs

Merck

Rigshospitalet

Lundbeckfonden

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/219/2/254/27276419/jiy442.pdf

Reference20 articles.

1. CD4+ count-guided interruption of antiretroviral treatment;El-Sadr;N Engl J Med,2006

2. Initiation of antiretroviral therapy in early asymptomatic HIV infection;Lundgren;N Engl J Med,2015

3. A trial of early antiretrovirals and isoniazid preventive therapy in Africa;Danel;N Engl J Med,2015

4. Antiretroviral therapy for the prevention of HIV-1 transmission;Cohen;N Engl J Med,2016

5. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study;Babiker;Clin Trials,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of CD4 cell count measures with infection-related and infection-unrelated cancer risk among people with HIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-05-09

2. Evaluating the use of antiviral drugs in HIV patients with cardiovascular diseases and how to reduce the incidence of cardiac events in these patients;American Journal of Cardiovascular Disease;2024

3. Real-world use of antiretroviral therapy and risk of cancer among people with HIV in Texas;AIDS;2023-11-22

4. HIV-associated lymphomas;Creative surgery and oncology;2023-01-05

5. Clonal Hematopoiesis Is Associated With Low CD4 Nadir and Increased Residual HIV Transcriptional Activity in Virally Suppressed Individuals With HIV;The Journal of Infectious Diseases;2021-08-21